Crixivan

In the US, Crixivan (indinavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

• Crixivan

UK matches:

• CRIXIVAN 200 mg Capsules
• CRIXIVAN 400 mg Capsules
• CRIXIVAN 200 mg and 400 mg hard capsules (SPC)

Ingredient matches for Crixivan

Indinavir

Indinavir is reported as an ingredient of Crixivan in the following countries:

• Ecuador


• Ethiopia


• Venezuela

Indinavir sulphate (a derivative of Indinavir) is reported as an ingredient of Crixivan in the following countries:

• Argentina


• Aruba


• Australia


• Austria


• Bahamas


• Bahrain


• Barbados


• Belgium


• Belize


• Bosnia & Herzegowina


• Brazil


• Bulgaria


• Canada


• Cayman Islands


• Chile


• China


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• El Salvador


• Finland


• France


• Georgia


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Jamaica


• Japan


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• Netherlands Antilles


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.